This week, Pharmac announced it was seeking feedback on the funding of medicines to treat paediatric cancer. It didn’t trigger a lot of noise. Many didn’t understand the context of the announcement, but the origins lie in a David and Goliath battle that took place in 2020, when many of us were
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
